COLL vs RL
Collegium Pharmaceutical Inc (COLL) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported RL revenue for 2025-03-29 was $7.08B. Net income was $742.9M. Revenue was up 6.7% from 2024-03-30 to 2025-03-29. RL currently screens at market cap $16.95B and trailing P/E 24.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the COLL and RL stock pages for the full models.
Not investment advice.